Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 2,812

Nice.

July 1, 2016 – C-RAD has received an order from its Chinese distributor for Catalyst™ and Sentinel™ systems, to be installed at leading cancer centers in China. The order has a total value of approximately 7.6 MSEK.

The Catalyst™ systems will be installed on Varian True Beam™ and Elekta Versa HD™ linear accelerators. The systems are delivered in different software configurations containing software modules for Patient Setup and Positioning and Respiratory Gating, including respective interfaces for communication with the treatment system. The interfaces allow a seamless integration for patient synchronization and an automated patient setup and beam control to treat tumors that may be moving due to respiratory motion.

Read more

General Motors is working with NASA and medical technologies company Bioservo to develop a battery-assisted robotic glove that can be used in assembly plants.

The technology was initially developed from a partnership between GM and NASA that resulted in RoboGlove, a force-multiplying tool that looks like a large electrified work glove.

The RoboGlove uses sensors and actuators comparable to the nerves, muscles and tendons in a human hand.

Read more

Glad it has been approved. This would have been great for BMI technology as well; however, FDA limits it to only treat clogged arteries.

WASHINGTON (AP) — A medical implant that slowly dissolves into the body could be the answer to long-standing safety concerns with devices used to treat clogged arteries.

But not so fast, say experts.

Abbott Laboratories’ newly-approved Absorb stent comes with one important caveat: it hasn’t yet been shown to be safer than older metal implants.

Read more

A newly published study details how engineers developed programmable RNA vaccines that work against Ebola, H1N1 influenza, and a common parasites in mice.

MIT engineers have developed a new type of easily customizable vaccine that can be manufactured in one week, allowing it to be rapidly deployed in response to disease outbreaks. So far, they have designed vaccines against Ebola, H1N1 influenza, and Toxoplasma gondii (a relative of the parasite that causes malaria), which were 100 percent effective in tests in mice.

The vaccine consists of strands of genetic material known as messenger RNA, which can be designed to code for any viral, bacterial, or parasitic protein. These molecules are then packaged into a molecule that delivers the RNA into cells, where it is translated into proteins that provoke an immune response from the host.

Read more

With the advantage of high resolution providing facial designs that can be created based on the FACS (facial active coding system), 3D photography scanning and printing of the subject will create images with connected feature grids. This allows the angles of the craniomaxillofacial surface to be observed for specific unique aspects of physical characteristics, for underlying anatomical bone structures based on eye to midline features.

The nasal process provides the centerpiece of anatomical facial mapping and organization which affects how the individual is viewed by the world around them. These connected grids with the aid of imaging allow for facial feature approximation for important craniofacial-facial planning creating vital structures that will be 3D printed according to accepted innovation in FACS (Facial active coding system) design. Medical grade silicone soft tissue prosthetics with colour are being created out of the UK with the Picsisma printer by Fripp Design as far back as 2013.

silicone pros

Read more

“May you live in interesting times,” resonates with many involved in the metal 3D printing industry, an ironic phrase regarded by some as a curse. Magnus René, CEO of the Arcam Group AB, might one of the last to agree. In the 3D metal printing market Arcam are unique. Holding propriety Electron Beam Melting (EBM) patents the company is at the forefront of cutting edge industries such as aerospace and medicine. I asked Arcam’s CEO about some of these developments.

René compares today’s additive manufacturing landscape to an earlier career experience in another industry at the frontier of technology.

“I was with a company that developed and released the [semiconductor] printers that are used still to this day for manufacture. Those were also interesting times, we really felt that we were changing the way things were manufactured.”

Read more